Fig. 2From: Healthy, mtDNA-mutationĀ free mesoangioblasts from mtDNA patients qualify for autologous therapySemi-quantitative analysis of large-scale mtDNA deletions in mesoangioblasts and skeletal muscle. The 16.5ākb mtDNA was PCR amplified and analyzed on a 0.7% agarosegel. M, mesoangioblasts; S, skeletal muscleBack to article page